A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis
Authors
Keywords
Glial fibrillary acidic protein, Multiple sclerosis, Meta-analysis, Systematic review
Journal
Multiple Sclerosis and Related Disorders
Volume -, Issue -, Pages 102870
Publisher
Elsevier BV
Online
2021-02-26
DOI
10.1016/j.msard.2021.102870
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum neurofilament light as a biomarker in progressive multiple sclerosis
- (2020) Raju Kapoor et al. NEUROLOGY
- Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
- (2020) Xavier Ayrignac et al. Scientific Reports
- A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course
- (2020) André Huss et al. Frontiers in Neurology
- Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack
- (2019) Xinguang Yang et al. Multiple Sclerosis and Related Disorders
- Serum GFAP as a biomarker for disease severity in multiple sclerosis
- (2018) A. Abdelhak et al. Scientific Reports
- Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
- (2018) Heidi Högel et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis
- (2016) M.Alba Mañé-Martínez et al. JOURNAL OF NEUROIMMUNOLOGY
- Disease-modifying treatments for multiple sclerosis - a review of approved medications
- (2015) Ø. Torkildsen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Role of the innate and adaptive immune responses in the course of multiple sclerosis
- (2015) Bernhard Hemmer et al. LANCET NEUROLOGY
- Serum GFAP levels in optic neuropathies
- (2012) Mithu Storoni et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis
- (2012) Roberto Madeddu et al. NEUROLOGICAL SCIENCES
- Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis
- (2010) M. Axelsson et al. JOURNAL OF NEUROLOGY
- MR Imaging in Multiple Sclerosis: Review and Recommendations for Current Practice
- (2009) K.-O. Lövblad et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- Axonal injury detected byin vivodiffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis
- (2007) Matthew D. Budde et al. NMR IN BIOMEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started